| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
73 Outperform | £1.58B | 12.42 | 5.88% | 1.18% | 9.51% | -31.96% | |
70 Outperform | £505.04M | 14.18 | 21.65% | ― | 11.35% | 248.63% | |
68 Neutral | £769.57M | 12.20 | 6.50% | 6.51% | -0.84% | -27.69% | |
57 Neutral | £403.51M | -11.85 | -6.79% | 6.30% | 3.31% | -340.97% | |
56 Neutral | £35.91M | 19.19 | 5.06% | ― | 13.75% | 51.63% | |
56 Neutral | £661.16M | 15.12 | -113.93% | 1.40% | 3.94% | ― |